© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
693157 |
As an accredited 6-Bromoimidazole[1,2-A]Pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromoimidazole[1,2-A]Pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For researchers who spend their time at the benchtop, a compound like 6-Bromoimidazole[1,2-A]Pyrimidine promises more than just a line on a lab inventory sheet. It stands out as an important heterocyclic building block, particularly because chemists are always searching for molecules that can open new avenues for targeted synthesis. This molecule, with its fused imidazole-pyrimidine core and bromine at the 6-position, offers unique reactivity that the more common, plain imidazole or pyrimidine derivatives lack.
From my own time running reactions, I remember the frustration of hunting for intermediates that don’t just repeat what’s already out there. The beauty of 6-Bromoimidazole[1,2-A]Pyrimidine lies in exactly that: it’s not just a generic halogenated ring. The bromine atom adds a lever for Suzuki or Buchwald-Hartwig couplings, unlocking access to a slate of potential analogues in pharmaceutical exploration. Traditional pyrimidines or imidazoles miss this targeted tunability.
Looking at this compound compared to something like plain imidazole often used as a base or a ligand, the brominated, fused-ring scaffold brings extra heft to the table. The fusion of imidazole and pyrimidine rings can lead to increased rigidity and unique electronic characteristics. These features are essential for researchers chasing selective kinase inhibitors, anti-infectives, or anti-cancer scaffolds. Pure pyrimidines, while classic, can be overused—sometimes you just see diminishing returns in terms of new biological activity. The fusion in this molecule delivers a platform that isn’t widely explored, and every medicinal chemist knows how valuable truly novel starting points can be.
Many researchers learn the hard way that not every halogenated precursor behaves predictably in cross-couplings, and sometimes the position of the bromine can make or break a whole synthetic plan. Here, the 6-position allows for specific downstream functionalization, and the unique ring fusion can avoid the pitfalls of undesired side reactions that often trouble other halogenated substrates. From personal experience, using 6-Bromoimidazole[1,2-A]Pyrimidine can reduce the usual time spent troubleshooting side products—a welcome change on days when you’re chasing yields or pure isolates for biological testing.
In actual lab use, chemists expect some common sense details from a compound they order. Purity, typically upwards of 97 percent by HPLC, shows up as a top concern. When impurities sneak in, or a batch comes through with too much by-product, it only complicates later steps and data interpretation. The melting point—an aspect some overlook—serves as an added check on quality and consistency. For this compound, the solid, crystalline form tends to make handling and storage straightforward, reducing risk of degradation over time. Stoichiometric accuracy, batch-to-batch repeatability, and transparent origin data build confidence among chemists who invest time and long-term research capital into new synthetic approaches.
This level of quality and documentation makes all the difference during early-stage discovery. As someone who’s spent time vetting materials from different sources, I’ve learned to trust suppliers who are open about how they measure purity, and who can provide supporting chromatograms when needed. Some competitors ship similar fused heterocycles with vague, one-line descriptions, but the lack of deep documentation creates delays or confusion at critical steps. A reliable, well-specified product saves weeks of unnecessary troubleshooting and batch rework.
In the real world, 6-Bromoimidazole[1,2-A]Pyrimidine finds its stride in organic synthesis, particularly in the creation of drug-like compounds. Scientists involved in target-based drug design often want to expand chemical space. With its well-positioned bromine atom, this molecule behaves reliably in palladium-catalyzed cross-couplings, providing a direct route to libraries of potential drug candidates that are both structurally diverse and functionally rich.
A key difference from other brominated aromatics comes down to the core structure. Most standard heterocycles, when brominated, either lack the robust rigidity offered by the fused imidazole-pyrimidine scaffold or prove more sensitive to heat and reagents in vigorous synthetic protocols. Here, the compound’s backbone means it stands up well in a variety of conditions, allowing for more aggressive conditions when necessary without rapid breakdown.
Beyond pure medicinal chemistry, this compound finds a place in fields like material science, where tailored electronics materials or molecular sensors rely on unique heterocyclic cores. The inclusion of bromine also means downstream halide-exchange reactions can introduce other functional groups without difficulty. Based on feedback from colleagues in materials chemistry, the consistent, crystalline nature of the product supports reproducibility in device fabrication—a step not every brominated heterocycle can claim.
One of the main questions researchers pose involves comparison: why reach for 6-Bromoimidazole[1,2-A]Pyrimidine instead of more familiar options? The answer often reveals itself during late-night troubleshooting or after several failed leads. Standard halogenated aromatics, like bromobenzene or even 2-bromopyridine, tend to show predictable reactivity but lack the three-dimensional complexity needed for next-level discovery. Even other fused heterocycles, like benzimidazoles with halogenation, present a different electronic environment—sometimes that difference means off-target activity or less favorable pharmacokinetics in preclinical models.
The impact of the dual ring fusion surfaces in both reactivity patterns and resulting compound libraries. When making analogues of kinase inhibitors, for example, the fused imidazole-pyrimidine offers hydrogen-bonding motifs and planarity mimicking ATP binding sites, a property medicinal chemists look to exploit. In parallel, plain pyrimidine cores historically see rapid metabolic clearance, a challenge often experienced after weeks of mouse dosing or failed in vitro screens. The additional rigidity and electronic differentiation from the imidazole cause changes in metabolic profile—based on published data, some analogues show improved in vivo stability. These subtle benefits rarely show up in a catalogue entry but play out in months saved off a discovery timeline.
Having purchased my fair share of research chemicals, I know that the difference between a successful reaction scheme and weeks wasted can often trace back to a vendor’s commitment to quality. What truly matters for a compound as nuanced as 6-Bromoimidazole[1,2-A]Pyrimidine lies both in the purity and the transparency around production. Top-tier suppliers offer supporting analytical data, including clean NMR spectra, mass spectrometry, and certificate of analysis for each lot. In my own projects, transparent batch history and access to impurity profiles historically allowed me to troubleshoot failed reactions quicker and validate results to collaborators.
Not every supplier meets high standards; some distribute bulk intermediates with bare minimum compliance, leading to ongoing debates with others on the research team about the root cause of yield issues or inconsistent biological data. Trusted vendors, by contrast, are open to discussions about custom scale or purity requests, giving research teams the ability to match a batch’s exact performance to the needs of a new synthetic method.
The applications of 6-Bromoimidazole[1,2-A]Pyrimidine stretch far beyond a single use-case. In medicinal chemistry, its core structure appeals to those searching for new kinase inhibitors, antiviral leads, or central nervous system modulators. I’ve seen research groups report that the fused scaffold helps to overcome hERG liabilities in some preclinical screens—a consideration that can derail whole programs if caught too late. In agrochemical research, the compound wins favor because the aromatic scaffold resists metabolic breakdown in plants, often conferring season-long stability in candidate fungicides or pesticides. Every time a research group finds a new use for the backbone, it tightens the argument for investing in such versatile starting points.
Material scientists also lean on this compound—its robust structure finds use in organic electronics, catalysis, and even some next-generation energy storage materials. A colleague in organic materials development described using this precise fused heterocycle to tune the bandgap in organic field-effect transistors, bringing performance upgrades without unwanted side reactions or decomposition during device processing.
One frustration in the lab involves substances that degrade unexpectedly. Based on the physical nature of 6-Bromoimidazole[1,2-A]Pyrimidine, lab storage doesn’t require elaborate precautionary steps such as inert gas atmosphere or ultra-cold conditions. More volatile or moisture-sensitive compounds have, in my experience, led to ruined stocks and costly re-orders. With this compound, I’ve kept bottles on the bench for extended periods with no visible changes or performance dips.
This kind of physical stability directly reduces waste. It grants chemists a measure of creative freedom—unplanned reaction trials or derivatizations become possible without worrying about the starting material’s viability. Such dependability in storage, handling, and reactivity means that researchers can devote attention to discovery rather than procurement.
A major challenge in drug discovery lies in moving away from crowded chemical space. Time and again, program teams stall in crowded areas of known molecular scaffolds, only to find fresh inspiration through underexplored cores like imidazo[1,2-a]pyrimidines. Adding a bromine atom at the 6-position provides a handle for diversification, keeping medicinal chemistry campaigns nimble.
Many teams struggle with hit-to-lead conversion as traditional chemical building blocks repeatedly deliver familiar, suboptimal leads. I’ve experienced firsthand the need for new vectors of diversification that avoid patent cliffs and open up new structure-activity relationships. Rather than cycling through scores of known pyrimidine analogues, turning to this fused-bromo system can revive momentum and spark new intellectual property opportunities. These practical lessons only come once a team breaks from old habits and invests in best-in-class intermediates.
Supply chain reliability leaves many scientists on edge. Delays or batch inconsistencies disrupt research timelines and can cost more in lost time than in pure financial outlay. My advice has always been to seek suppliers who invest in transparent production records and provide customizable options—one size seldom fits all. In a crowded research market, only certain vendors offer technical support along with their product, giving research teams real backup during troubleshooting.
Another struggle involves documentation. Insufficient analytical disclosure from some sources forces redundant verification efforts or throws uncertainty onto established protocols. To tackle this, some leading vendors now include more than just a certificate of analysis—NMR spectra, impurity profiling, and batch certificates can restore peace of mind and save whole weeks of redundant work.
Access to novel building blocks also depends on fair pricing and availability of multiple scales, especially for academic groups or startups working under tight constraints. Some companies have responded by offering tiered bulk pricing and custom synthesis routes for special needs, opening access to compounds like 6-Bromoimidazole[1,2-A]Pyrimidine for innovators with limited budgets but big ambitions.
Safety forms a cornerstone in any discussion about chemical reagents. As labs move toward greener and more sustainable practices, the choice of building blocks plays a major role in reducing hazard and waste. 6-Bromoimidazole[1,2-A]Pyrimidine, by its physical makeup, supports safe storage and predictable reactivity, reducing unforeseen exposure risks. Responsible researchers read beyond the headline hazard codes to embrace training and secondary containment. Every responsible user respects the importance of handling all chemicals with care, especially in shared spaces.
As emerging therapeutic targets and innovative materials demand ever-more inventive molecules, the chemical community leans increasingly on scaffolds that bring more than one advantage. 6-Bromoimidazole[1,2-A]Pyrimidine occupies an important space because it gives researchers a springboard for new chemistry while supporting rigorous documentation and repeatable performance. In practice, success in modern chemistry relies on both the creative core and the dependability of inputs.
Teams embracing this approach report fewer surprises, smoother reaction workflows, and more robust data, which translate to bigger long-term wins for those bold enough to push beyond conventional starting points. From personal experience and ongoing feedback in the community, compounds built around advanced, fused heterocycles now underpin major advances both in labs and products headed for real-world application.
Even favorite reagents present obstacles. Sometimes a reaction proceeds sluggishly, or an unexpected byproduct creeps in. This is especially true for rare, fused heterocycles. Labs that standardize on top-purity, well-documented batches have better odds against these frustrations. Direct communication between supplier and bench chemist remains a critical factor in the timely resolution of issues. Swift support in method troubleshooting can mean the difference between a successful scale-up and months of abandoned work.
Chemists who take initiative to optimize reaction conditions—adapting base, solvent, or temperature—usually get the most mileage out of bromo-fused rings. My own journey with these compounds includes hours spent screening palladium sources and ligand combinations. This work pays off, yielding robust, versatile synthons for everything from fragment-based drug discovery to custom fluorescent markers.
Looking to the future, research hinges on expanding the available set of trusted building blocks. 6-Bromoimidazole[1,2-A]Pyrimidine takes a step in precisely that direction, anchoring ambitious research programs with a foundation of reliability and innovation. It serves as proof that chemistry still evolves—not just to create better molecules but also to improve every stage of research along the way.
I’ve seen firsthand how a dependable, well-characterized intermediate can restore lost momentum on a struggling project or open possibility for a completely new line of investigation. Going forward, compounds like 6-Bromoimidazole[1,2-A]Pyrimidine will fuel progress—from early project brainstorming to clinical or commercial realization, they hold a promise not just to meet needs but to spark the next wave of research breakthroughs.
